Endoplasmic reticulum stress: A common pharmacologic target of cardioprotective drugs.

Mooradian, Arshag D; Haas, Michael J

Mooradian, Arshag D; Haas, Michael J.

Affiliation

Mooradian AD; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Florida College of Medicine, Jacksonville, FL, USA. Electronic address: arshag.mooradian@jax.ufl.edu.
Haas MJ; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Florida College of Medicine, Jacksonville, FL, USA.

Eur J Pharmacol ; 931: 175221, 2022 Sep 15.

Article in En | MEDLINE | ID: mdl-35998751

Subject(s)

Cardiovascular Diseases; Endoplasmic Reticulum Stress; Humans; Adrenergic beta-Antagonists/pharmacology; Angiotensin Receptor Antagonists/pharmacology; Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/prevention & control; Sodium-Glucose Transporter 2 Inhibitors/pharmacology

Key words

Cardioprotection; Cellular stress; Endoplasmic reticulum

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Endoplasmic Reticulum Stress Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google